Larry Hester, a Second Sight patient and bionic eye recipient, and Dr. Robert Greenberg, chief executive officer at Second Sight, discuss the breakthrough of restoring partial eyesight using robotics and explain the technology and business behind the eye implant. They speak on “Market Makers.”
Larry Hester, a Second Sight patient and bionic eye recipient, and Dr. Robert Greenberg, chief executive officer at Second Sight, discuss the breakthrough of restoring partial eyesight using robotics and explain the technology and business behind the eye implant. They speak on “Market Makers.”
Subscribe to our FREE monthly newsletter and see how many of our readers have made thousands in PROFITS with our ideas
SpaceX is back near its $135 IPO price as insider shares unlock. Rapid growth, rising AI revenue and a staggered release calendar may give patient investors an entry point.
Artificial intelligence is taking over millions of jobs, but you have a choice: do this or get left behind.
Join the race against time and explore the world of cellular reprogramming. Discover how tech billionaires are investing in innovations that could extend our health and lifespan.
Venture capital firms (VCs) and investment banks are now front-running the biggest upcoming trend with something more predictable than inside information. And this is what they're betting on.
From portals to black holes, here's the basics of what CERN's Large Hadron Collider really is and what it means for the world.
AI and bots have overtaken information and now they're after your communications. Soon, they will control the narrative and you will be silenced.
